NGM Biopharmaceuticals, Inc. Operating Margin 2019-2023 | NGM
Current and historical operating margin for NGM Biopharmaceuticals, Inc. (NGM) over the last 10 years. The current operating profit margin for NGM Biopharmaceuticals, Inc. as of December 31, 2023 is %.
| Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2023-12-31 | $0.00B | $-0.15B | -3800.00% |
| 2023-09-30 | $0.02B | $-0.16B | -727.27% |
| 2023-06-30 | $0.03B | $-0.18B | -610.34% |
| 2023-03-31 | $0.04B | $-0.18B | -508.33% |
| 2022-12-31 | $0.06B | $-0.17B | -301.82% |
| 2022-09-30 | $0.06B | $-0.16B | -267.24% |
| 2022-06-30 | $0.07B | $-0.14B | -197.10% |
| 2022-03-31 | $0.08B | $-0.13B | -161.54% |
| 2021-12-31 | $0.08B | $-0.12B | -153.16% |
| 2021-09-30 | $0.08B | $-0.12B | -156.41% |
| 2021-06-30 | $0.08B | $-0.12B | -150.00% |
| 2021-03-31 | $0.09B | $-0.11B | -131.76% |
| 2020-12-31 | $0.09B | $-0.11B | -120.69% |
| 2020-09-30 | $0.10B | $-0.09B | -95.92% |
| 2020-06-30 | $0.10B | $-0.08B | -79.38% |
| 2020-03-31 | $0.10B | $-0.06B | -59.80% |
| 2019-12-31 | $0.10B | $-0.05B | -47.12% |
| 2019-09-30 | $0.12B | $-0.02B | -15.83% |
| 2019-06-30 | $0.12B | $-0.01B | -11.76% |
| 2019-03-31 | $0.12B | $-0.01B | -6.90% |
| 2018-12-31 | $0.11B | $-0.00B | -3.67% |
